Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance

Mycoses

Volumn 54, Issue 4, 2011, Pages

  Ghannoum, M A ^a   Herbert, J ^a   Isham, N ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Candida; Miconazole; Susceptibility

Indexed keywords

FLUCONAZOLE; MICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; DILUTION; DRUG REEXPOSURE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; HUMANS; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; MUTATION; SERIAL PASSAGE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS;

EID: 79959220204     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01867.x     Document Type: Article

References (11)

1. Pienaar ED, Young T, Holmes H Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst Rev 2006;16:3:CD003940.
2. Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006; 42: 698-702.
3. Ruhnke M. Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr Drug Targets 2006; 7: 495-504.
4. Redding SW, Kirkpatrick WR, Dib O et al. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist 2000; 20: 178-81.
5. Isham N, Ghannoum MA. Antifungal activity of miconazole against recent Candida strains. Mycoses 2009: Epub ahead of print.
6. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - second edition. CLSI document M27-A2 (ISBN 1-56238-469-4). Wayne, PA: CLSI, 2002.
7. Barry AL, Pfaller MA, Rennie RP et al. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, etest, and disk diffusion methods. Antimicrob Agents Chemother 2002; 46: 1781-4.
8. CLSI. Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline - second edition. CLSI document M23-A2 (ISBN 1-56238-435-X). Wayne, PA: CLSI, 2001.
9. Barchiesi F, Calabrese D, Sanglard D et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 2000; 44: 1578-84.
10. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-76.
11. Zhu YN, Lu SM. Study on experimental induction of fluconazole resistance in Candida albicans. Shi Yan Sheng Wu Xue Bao 2004; 37: 418-22.